The Journal of Immunology, Vol 157, Issue 9 3783-3790, Copyright © 1996 by American Association of Immunologists

ARTICLES

Response of a human T cell clone to a large panel of altered peptide ligands carrying single residue substitutions in an antigenic peptide: characterization and frequencies of TCR agonism and TCR antagonism with or without partial activation

YZ Chen, S Matsushita and Y Nishimura
Department of Neuroscience and Immunology, Kumamoto University Graduate School of Medical Sciences, Japan.

A CD4+ human T cell clone YN5-32 recognized a streptococcal M12p54-68 peptide in the context of HLA-DR4 and produced a large amount of IFN- gamma. We investigated responses of YN5-32 to 156 independent analogue peptides carrying single residue substitutions at residues 57 (position 1 (p1)) to 65 (p9) of the peptide. Approximately 30% of analogues at either Leu57 (p1), Ala60 (p4), or Asn62 (p6) residues exhibited TCR agonism to stimulate various magnitudes of proliferative responses in the T cell clone, and analogues exhibiting TCR antagonism are rare in these three residues. In analogues at either Glu58 (p2), Gln59 (p3), Tyr61 (p5), or Glu63 (p7) residue, 30 to 50% exhibited TCR antagonism. About 10% of analogues at Glu58 (p2) or Tyr61 (p5) stimulated proliferative responses, while 30 to 50% of analogues at Gln59 (p3) or Glu63 (p7) did so. Some of these TCR antagonistic analogues carrying relatively conservative amino acid substitutions partially activated the T cells to induce large increases in size and expression levels of CD4, CD11a (LFA-1), CD28, CD49d (VLA-4), and CD95 (Fas), and small increases in CD25 and CD44 expressions on the cell surface. None of the partially activating antagonistic analogues induced IFN-gamma production or anergy in T cells. Analogues with replacements of acidic amino acids at either Leu64 (p8) or Ser65 (p9) residue had dominant negative effects on T cell proliferation. Thus, altered peptide ligands with single residue substitutions in the antigenic peptide frequently stimulated the human T cell clone, in at least three different ways to exhibit agonism, antagonism, and antagonism with partial activation. Frequencies of analogue peptides exhibiting these three different effects on the T cell clone differed depending on the residue of the peptide substituted. Altered T cell responses induced by analogue peptides of a T cell epitope provide a system to analyze activation signals mediated by TCR, and to manipulate T cell responses.

This article has been cited by other articles:

				A. Kawano, S. Shimoda, T. Kamihira, F. Ishikawa, H. Niiro, Y. Soejima, A. Taketomi, Y. Maehara, M. Nakamura, A. Komori, et al. Peripheral Tolerance and the Qualitative Characteristics of Autoreactive T Cell Clones in Primary Biliary Cirrhosis J. Immunol., September 1, 2007; 179(5): 3315 - 3324. [Abstract] [Full Text] [PDF]

				A. Irie, K. Harada, H. Tsukamoto, J.-R. Kim, N. Araki, and Y. Nishimura Protein kinase D2 contributes to either IL-2 promoter regulation or induction of cell death upon TCR stimulation depending on its activity in Jurkat cells Int. Immunol., December 1, 2006; 18(12): 1737 - 1747. [Abstract] [Full Text] [PDF]

				H. Tsukamoto, A. Irie, and Y. Nishimura B-Raf Contributes to Sustained Extracellular Signal-regulated Kinase Activation Associated with Interleukin-2 Production Stimulated through the T Cell Receptor J. Biol. Chem., November 12, 2004; 279(46): 48457 - 48465. [Abstract] [Full Text] [PDF]

				Y. Uemura, S. Senju, K. Maenaka, L. K. Iwai, S. Fujii, H. Tabata, H. Tsukamoto, S. Hirata, Y.-Z. Chen, and Y. Nishimura Systematic Analysis of the Combinatorial Nature of Epitopes Recognized by TCR Leads to Identification of Mimicry Epitopes for Glutamic Acid Decarboxylase 65-Specific TCRs J. Immunol., January 15, 2003; 170(2): 947 - 960. [Abstract] [Full Text] [PDF]

				Z.-F. Lai, Y.-Z. Chen, Y. Nishimura, and K. Nishi An Amiloride-Sensitive and Voltage-Dependent Na+ Channel in an HLA-DR-Restricted Human T Cell Clone J. Immunol., July 1, 2000; 165(1): 83 - 90. [Abstract] [Full Text] [PDF]

				H. Toh, N. Kamikawaji, T. Tana, S. Muta, T. Sasazuki, and S. Kuhara Magnitude of structural changes of the T-cell receptor binding regions determine the strength of T-cell antagonism: molecular dynamics simulations of HLA-DR4 (DRB1*0405) complexed with analogue peptide Protein Eng. Des. Sel., June 1, 2000; 13(6): 423 - 429. [Abstract] [Full Text] [PDF]

				R. D. J. Huby, R. J. Dearman, and I. Kimber Why Are Some Proteins Allergens? Toxicol. Sci., June 1, 2000; 55(2): 235 - 246. [Abstract] [Full Text] [PDF]

				H. J. Hernandez and M. J. Stadecker Elucidation and Role of Critical Residues of Immunodominant Peptide Associated with T Cell-Mediated Parasitic Disease J. Immunol., October 1, 1999; 163(7): 3877 - 3882. [Abstract] [Full Text] [PDF]

				Y. Tanaka, H. Ohyama, M. Ogawa, Y. Nishimura, and S. Matsushita Identification of Peptide Superagonists for a Self-K-ras-Reactive CD4+ T Cell Clone Using Combinatorial Peptide Libraries and Mass Spectrometry J. Immunol., June 15, 1999; 162(12): 7155 - 7161. [Abstract] [Full Text] [PDF]

				T. M. Clay, M. C. Custer, M. D. McKee, M. Parkhurst, P. F. Robbins, K. Kerstann, J. Wunderlich, S. A. Rosenberg, and M. I. Nishimura Changes in the Fine Specificity of gp100(209-217)-Reactive T Cells in Patients Following Vaccination with a Peptide Modified at an HLA-A2.1 Anchor Residue J. Immunol., February 1, 1999; 162(3): 1749 - 1755. [Abstract] [Full Text] [PDF]

				E. Reali, R. Guerrini, M. Marastoni, R. Tomatis, M. Grazia Masucci, S. Traniello, and R. Gavioli A Single Specific Amino Acid Residue in Peptide Antigens Is Sufficient to Activate Memory CTL: Potential Role of Cross-Reactive Peptides in Memory T Cell Maintenance J. Immunol., January 1, 1999; 162(1): 106 - 113. [Abstract] [Full Text] [PDF]

				S. von Greyerz, M. P. Zanni, K. Frutig, B. Schnyder, C. Burkhart, and W. J. Pichler Interaction of Sulfonamide Derivatives with the TCR of Sulfamethoxazole-Specific Human {alpha}{beta}+ T Cell Clones J. Immunol., January 1, 1999; 162(1): 595 - 602. [Abstract] [Full Text] [PDF]

				D. Basu, C. B. Williams, and P. M. Allen In vivo antagonism of a T cell response by an endogenously expressed ligand PNAS, November 24, 1998; 95(24): 14332 - 14336. [Abstract] [Full Text] [PDF]

				M. G. von Herrath, B. Coon, H. Lewicki, H. Mazarguil, J. E. Gairin, and M. B. A. Oldstone In Vivo Treatment with a MHC Class I-Restricted Blocking Peptide Can Prevent Virus-Induced Autoimmune Diabetes J. Immunol., November 1, 1998; 161(9): 5087 - 5096. [Abstract] [Full Text] [PDF]

				B. Hemmer, I. Stefanova, M. Vergelli, R. N. Germain, and R. Martin Relationships Among TCR Ligand Potency, Thresholds for Effector Function Elicitation, and the Quality of Early Signaling Events in Human T Cells J. Immunol., June 15, 1998; 160(12): 5807 - 5814. [Abstract] [Full Text] [PDF]

				B. Hemmer, M. Vergelli, B. Gran, N. Ling, P. Conlon, C. Pinilla, R. Houghten, H. F. McFarland, and R. Martin Cutting Edge: Predictable TCR Antigen Recognition Based on Peptide Scans Leads to the Identification of Agonist Ligands with No Sequence Homology J. Immunol., April 15, 1998; 160(8): 3631 - 3636. [Abstract] [Full Text] [PDF]